|
68. Perfluorooctanoic
acid (PFOA) CAS No 335-67-1
EC No
206-397-9
and its
salts.
Any related
substance (including its salts and polymers) having a linear or branched
perfluoroheptyl group with the formula C7F15- directly attached to another
carbon atom, as one of the structural elements.
Any
related substance (including its salts and polymers) having a linear or
branched perfluorooctyl group with the formula C8F17- as one of the
structural elements.
The
following substances are excluded from this designation:
C8F17-X,
where X= F, Cl, Br.
C8F17-C(=O)O-X or C8F17-CF2-X (where X=any group, including salts).
|
1. Shall
not be manufactured, or placed on the market as substances on their own from
[date 每 3 years after date of entry into force of this Regulation].
2. Shall
not, from [date 每 3 years after date of entry into force of this
Regulation], be used in the production of, or placed on the market in:
(a)
another substance, as a constituent;
(b) a
mixture;
(c) an
article, or any part thereof
in a
concentration equal to or above 25 ppb of PFOA including its salts or 1000
ppb of one or a combination of PFOA-related substances.
3.
Paragraphs 1 and 2 shall apply from:
(a) [date
- 5 years after entry into force of this Regulation] to:
(i) equipment
used to manufacture semi-conductors;
(ii) latex
printing inks.
(b) [date
每 6 years after entry into force of this Regulation] to:
(i)
textiles for the protection of workers that must meet durable water
repellency (DWR) performance standards;
(ii) membranes
intended for use in medical textiles, filtration in water treatment,
production processes and effluent treatment;
(iii)
plasma nano-coatings.
(c) [date
每 15 years after entry into force of this Regulation] to medical devices
other than implantable medical devices within the scope of Directive
93/42/EEC.
4.
Paragraphs 1 and 2 shall not apply to any of the following:
(a)
perfluorooctane sulfonic acid and its derivatives, which are listed in Part A
of Annex I to Regulation (EC) No 850/2004;
(b) the
manufacture of a substance where this occurs as an unavoidable by-product of
the manufacture of fluorochemicals with a carbon chain equal to or shorter
than 6 atoms;
(c) a
substance that is to be used, or is used as a transported isolated intermediate,
provided that the conditions in points (a) to (f) of Article 18(4) of this
Regulation are met;
(d) a
substance, constituent of another substance or mixture that is to be used, or
is used:
(i) in the
production of implantable medical devices within the scope of Directive
93/42/EEC;
(ii) in
photographic coatings applied to films, papers or printing plates;
(iii) in
semiconductor photo-lithography processes or in etching processes for
compound semiconductors;
(e)
concentrated fire-fighting foam mixtures that were placed on the market
before [date 每 3 years after date of entry into force of this Regulation]
and are to be used, or are used in the production of other fire-fighting foam
mixtures.
5.
Paragraph 2(b) shall not apply to fire-fighting foam mixtures which were:
(a) placed
on the market before [date 每 3 years after entry into force of this
Regulation]; or
(b)
produced in accordance with paragraph 4(e),
provided
that, where they are used for training purposes, emissions to the environment
are minimised and effluents collected are safely disposed of.
6. Paragraph 2(c) shall not apply to:
(a)
articles placed on the market before [date 每 3 years after date of entry
into force of this Regulation];
(b)
implantable medical devices produced in accordance with point (i) of
paragraph 4(d);
(c)
articles coated with the photographic coatings referred to in point (ii) of
paragraph 4(d);
(d)
compound semiconductors referred to in point (iii) of paragraph 4(d).§
|
